Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.67
(
-0.98%
)
Bitcoin
74,303.38
(
0.49%
)
News Focus
News Focus

Replies to post #9388 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #9388 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

07/19/12 11:54 AM

#9390 RE: jbog #9388

In general, non-interchangeable FoB’s—which is what all of NVS’ FoB’s are—are not going to be big-selling drugs. That’s the whole premise of what MNTA is trying to accomplish with BAX.